Desk›Healthcare› Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics Ltd
BSE 540788 · NSE ASPIRA · ISIN INE500C01017 · Group XT · Active
Healthcare › Healthcare › Healthcare Services › Healthcare Service Provider
₹91.50
+1.95%
BSE close, 28 August 2026
₹94.18 cr
1.0 cr shares · Micro cap
₹40.65 cr
as published
-207.9× · 8.47×
EPS ₹-0.44 · BV ₹10.80
24.98 / 0.05
₹ cr, as filed
25
5 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -32.7% |
|---|---|
| Against 52-week low | +86.7% |
| Day change | +1.95% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.44 |
|---|---|
| Price / earnings | -207.95× |
| Price / book | 8.47× |
| Book value — derived, price ÷ P/B | ₹10.80 |
| Return on equity | -4.07% |
| Operating margin | 7.51% |
| Net margin | -0.62% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -4.07%
- ROE as published
- -4.07%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 6.17 | -0.04 | -0.04 | 7.51% | -0.62% |
| Mar-26 · Q | 6.52 | -0.69 | -0.67 | -2.97% | -10.56% |
| FY25-26 | 24.98 | 0.05 | 0.05 | 7.92% | 0.20% |
Quarter on quarter
- Revenue, quarter on quarter
- -5.4%
- Net profit, quarter on quarter
- +94.2%
- Operating margin, quarter on quarter
- +1,048 bps
Disclosure profile 25 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| KMP | 1 |
| Resignation | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| SAST | 5 |
| AGM / EGM | 3 |
| Newspaper Publication | 3 |
| Board Meeting | 2 |
| General | 2 |
| Annual Report | 1 |
| Book Closure | 1 |
| Compliance Certificate | 1 |
| Other Update | 1 |
| Trading Window | 1 |
| Procedural sub-total | 20 |
| Total | 25 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group XT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
25 filings · 5 selected · busiest 2026-08-03
Filing rhythm · the twelve most recent
2026-08-312026-10-08
SelectedProcedural
Filings
25 in the window · 8 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under reg 74(5) of SEBI (DP) regulation, 2018 for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
1 October 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
28 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
25 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report
AGM/EGM / AGM View filing →
-
25 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached summary of proceeding /outcome of the 53rd Annual General Meeting of the Company held on Friday,25th September,2026
AGM/EGM / AGM View filing →
-
23 September 2026 ·
Closure of Trading Window
Closure of Trading Window for quarter ended September 30,2026
Insider Trading / SAST / Closure of Trading Window View filing →
-
16 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
7 September 2026 ·
Board Meeting Intimation for To Consider Approve The Proposal For Raising Funds Through The Issuance Of Equity Shares, Warrants Convertible Into Equity Shares, Or Other Permitted Instruments By Way Of Preferential Issue, Private Placement, Rights Issue Or Any Combination.
Aspira Pathlab & Diagnostics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/09/2026 ,inter alia, to consider and approve To consider approve ....
Board Meeting / Board Meeting View filing →
-
3 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
1 September 2026 ·
Letters Dispatched To Non-Email Shareholders
Pursuant to Regulation 36 (1)(b) of SEBI (LODR)2015, The Company has dispatched letter containing weblink of Annual Report for Financial year 2025-26
Company Update / General View filing →
-
1 September 2026 ·
Newspaper Publication
Newspaper Publication Post Dispatch of 53rd AGM Notice & Annual Report for the Financial Year 2025-26
Company Update / Newspaper Publication View filing →
-
31 August 2026 ·
Reg. 34 (1) Annual Report.
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of the Notice of ....
Others / Reg. 34 (1) Annual Report View filing →
-
31 August 2026 ·
Notice Convening 53Rd Annual General Meeting To Be Held On Friday, September 25, 2026 At 02.00 P.M Through Video Conferencing Mode.
Intimation of Notice of 53rd Annual General Meeting for the Financial Year 2025-26
AGM/EGM / AGM View filing →
-
31 August 2026 ·
Intimation Of Book Closure Date, Notice Of The 53Rd Annual General Meeting And E-Voting Date
With reference to subject matter please find the attached Documents
Corp. Action / Book Closure View filing →
-
28 August 2026 ·
Newspaper Publication
Newspaper Advertisement - Information Regarding 53rd (Fifty -Three) Annual General Meeting of the company
Company Update / Newspaper Publication View filing →
-
28 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026 ·
Newspaper Publication
Newspaper Publication for the Financial Result as on 30 June 2026
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Change in Management
1. Board approved the appointment of Mr. Vaibhav Odhekar as Additional Executive Director with immediate Effect. 2. Board Approved the regularization of Mr. Vaibhav Odhekar as Executive ....
Company Update / Change in Management View filing →
-
12 August 2026 ·
Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026
Unaudited Standalone Financial Results for quarter ended 30 June 2026
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026
Outcome of Board Meeting held on 12th August 2026
Board Meeting / Outcome of Board Meeting View filing →
-
6 August 2026 ·
Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 30,2026 And To Transact Other Businesses
Aspira Pathlab & Diagnostics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1.Unaudited Financial ....
Board Meeting / Board Meeting View filing →
-
3 August 2026 ·
Resignation Of Internal Auditor
Enclosed herewith Resignation of M/s Vishal J Bhanushali and Associated with effect from 13th August 2026
Company Update / General View filing →
-
3 August 2026 ·
Resignation of Chief Executive Officer (CEO)
Enclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director and Chief Executive Officer with effect from 03.08.2026
Company Update / Resignation of Chief Executive Officer (CEO) View filing →
-
3 August 2026 ·
Resignation of Managing Director
Enclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director cum Chief Executive Officer with effect from 03.08.2026
Company Update / Resignation of Managing Director View filing →
-
3 August 2026 ·
Resignation of Director
Enclosed herewith Resignation of Pankaj jashwant Shah (DIN:02836324)
Company Update / Resignation of Director View filing →
RSS feed for Aspira Pathlab & Diagnostics Ltd · the 50 most recent filings